Abstract:Background: Dynapenic obesity is a condition characterized by high adiposity levels combined with muscle dysfunction. Although high adiposity and muscle loss/dysfunction are thought to synergistically increase the risk of cardiovascular disease (CVD), few studies have addressed the association between dynapenic and sarcopenic obesity and CVD. We aimed to investigate the association of dynapenic obesity with incident CVD events using the data from a population-based prospective longitudinal study in Japan. Methods: A total of 2490 community-dwelling Japanese aged 40-79 years (42.5% males, mean age 57.7 ± 10.6 years) without a history of CVD were followed up for a median of 24 years. Handgrip strength was classified as low, medium, or high by age- and sex-specific tertiles. Body mass index (BMI) levels were categorized as lean (<18.5 kg/m2), normal (18.5-24.9 kg/m2), or obese (≥25.0 kg/m2). Dynapenic obesity was defined as having both low handgrip strength and obesity. The outcomes were defined as the first-ever development of CVD (defined as stroke or coronary heart disease). The hazard ratios (HRs) and their 95% confidence intervals (CIs) for the development of CVD were estimated using a Cox proportional hazards model, in which participants with high handgrip strength and normal BMI were used as a reference group. Mediation analyses used serum high-sensitivity C-reactive protein (hs-CRP) and homeostatic model assessment for insulin resistance (HOMA-IR) as mediators. Results: During the follow-up period, 482 participants developed CVD events (324 cases of stroke and 209 of coronary heart disease). The multivariable-adjusted risk of CVD increased significantly among participants with dynapenic obesity compared with the reference group (HR 1.49, 95% CI 1.03-2.17). An analysis by age groups showed a further increase in the risk of CVD among participants with dynapenic obesity aged less than 65 years (HR 1.66, 95% CI 1.04-2.65). In mediation analyses for participants aged less than 65 years, serum hs-CRP was shown to be a significant mediator explaining 13.8% of the association between dynapenic obesity and the development of CVD, while HOMA-IR explained 12.2% of this relationship. Conclusions: Dynapenic obesity was a significant risk factor for the development of CVD in a general Japanese population. This association was more pronounced among those aged <65 years. Inflammation, and possibly glucose metabolism, might partly mediate this association. Our findings suggest that preventing muscle dysfunction as well as appropriate weight control, especially in middle-age, are important for preventing the development of CVD.

Obesity cardiomyopathy could contribute to sudden cardiac death: a Japanese epidemiological morphological study

Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the General Population　- Analysis of a Nationwide Epidemiological Database.

Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications

Obesity-Related Myocardiopathy

Effect of Obesity on Cardiac Morphological Changes and Clinical Prognosis in Patients with Hypertrophic Cardiomyopathy

Myocardial Tissue-Level Characteristics of Adults With Metabolically Healthy Obesity

Exploring factors associated with increased suicides during the COVID-19 pandemic in Japan: A study using data from postmortem examinations conducted in an urban area

Postmorterm Computed Tomography and Autopsy to Confirm Sudden Death Due to Tracheal Compression by Mediastinal Fat Tissue in a Young Man With Obesity

[Fat cardiomyopathy in patients with severe degree of obesity. Case report]

Association between dynapenic obesity and risk of cardiovascular disease: The Hisayama study

Observational study on obesity: Insights from middle-aged and elderly college staff in Beijing

Relationship between obesity and hypertrophic or dilated cardiomyopathy: the role of sex

Body Mass Index and Outcomes in Patients with Takotsubo Syndrome: A Nationwide Retrospective Cohort Study

Obesity‐dependent molecular alterations in fatal COVID‐19: A retrospective postmortem study of metabolomic profile of adipose tissue

Association of body indices with mortality in older population: Japan Specific Health Checkups (J‐SHC) Study

Myocardial Geometry and Dysfunction in Morbidly Obese Adolescents (BMI 35-40 kg/m2)

Cardiomyopathy in obesity, insulin resistance and diabetes

Causes of Sudden Death in Patients with Obstructive Sleep Apnea.

Metabolically healthy obesity and risks of cardiovascular disease and all-cause mortality, a matched cohort study: the Shizuoka study

Impact of Cardiovascular Disease on the Death Certificate Diagnosis of Heart Failure, Ischemic Heart Disease, and Cerebrovascular Disease - The Japan Public Health Center-Based Prospective Study

Association of excess visceral fat and severe illness in hospitalized COVID-19 patients in Japan: a retrospective cohort study